Protalix Biotherapeutics Inc (PLX) has gained 1.18% Friday In Premarket Trading

Protalix Biotherapeutics Inc (PLX) has gained Friday morning, with the stock adding 1.18% in pre-market trading to 1.71. PLX's short-term technical score of 17 indicates that the stock has traded less bullishly over the last month than 83% of stocks on the market. In the Biotechnology industry, which ranks 131 out of 146 industries, PLX ranks higher than 31% of stocks. Protalix Biotherapeutics Inc has risen 4.32% over the past month, closing at $1.64 on October 6. During this period of time, the stock fell as low as $1.43 and as high as $1.67. PLX has an average analyst recommendation of Strong Buy. The company has an average price target of $13.00.

PLX has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on PLX!

See Full PLX Report

Protalix Biotherapeutics Inc has a Long-Term Technical rank of 60. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 40% of the market scoring higher. In the Biotechnology industry which is number 132 by this metric, PLX ranks better than 132% of stocks.

Important Dates for Investors in PLX:

-Protalix Biotherapeutics Inc is set to release earnings on 2023-11-06. Over the last 12 months, the company has reported EPS of $0.01. -We do not have a set dividend date for Protalix Biotherapeutics Inc at this time. Click Here To Get The Full Report on Protalix Biotherapeutics Inc (PLX)